277 related articles for article (PubMed ID: 12624626)
21. Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden.
Graf LL; Welsh CH; Qamar Z; Marlar RA
Am J Clin Pathol; 2003 Jan; 119(1):52-60. PubMed ID: 12520697
[TBL] [Abstract][Full Text] [Related]
22. Primary thrombophilia in Mexico IV: frequency of the Leiden, Cambridge, Hong Kong, Liverpool and HR2 haplotype polymorphisms in the factor V gene of a group of thrombophilic Mexican Mestizo patients.
Ruiz-Argüelles GJ; Poblete-Naredo I; Reyes-Núñez V; Garcés-Eisele J; López-Martínez B; Gómez-Rangel JD
Rev Invest Clin; 2004; 56(5):600-4. PubMed ID: 15776863
[TBL] [Abstract][Full Text] [Related]
23. Resistance to activated protein C--frequent etiologic factor for venous thrombosis.
Simkova M; Simko F; Kovacs L
Bratisl Lek Listy; 2001; 102(5):240-7. PubMed ID: 11725376
[TBL] [Abstract][Full Text] [Related]
24. FV HR2 haplotype as additional inherited risk factor for deep vein thrombosis in individuals with a high-risk profile.
Margaglione M; Bossone A; Coalizzo D; D'Andrea G; Brancaccio V; Ciampa A; Grandone E; Di MG
Thromb Haemost; 2002 Jan; 87(1):32-6. PubMed ID: 11848454
[TBL] [Abstract][Full Text] [Related]
25. Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss.
Younis JS; Brenner B; Ohel G; Tal J; Lanir N; Ben-Ami M
Am J Reprod Immunol; 2000 Jan; 43(1):31-5. PubMed ID: 10698038
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of role of FV, FVIII and APLAs in the pathogenesis of APCR in FV Leiden negative DVT patients: a study in India.
Sharma A; Singh K; Biswas A; Ranjan R; Kishor K; Kumar R; Pandey H; Kamal VK; Saxena R
J Thromb Thrombolysis; 2017 Feb; 43(2):217-223. PubMed ID: 28063132
[TBL] [Abstract][Full Text] [Related]
27. The factor V gene A4070G mutation and the risk of venous thrombosis.
Alhenc-Gelas M; Nicaud V; Gandrille S; van Dreden P; Amiral J; Aubry ML; Fiessinger JN; Emmerich J; Aiach M
Thromb Haemost; 1999 Feb; 81(2):193-7. PubMed ID: 10063990
[TBL] [Abstract][Full Text] [Related]
28. [Activated C protein resistance: laboratory study and prevalence of the defect in the Chilean population].
Pereira J; Quiroga T; Goycoolea M; Muñoz B; Hidalgo P; Kaltwasser G; Mezzano D
Rev Med Chil; 1996 Jun; 124(6):663-8. PubMed ID: 9041721
[TBL] [Abstract][Full Text] [Related]
29. Detection of factor V Leiden in Thai patients with venous thrombosis.
Prayoonwiwat W; Arnutti P; Hiyoshi M; Nathalang O; Suwanasophon C; Kokaseam R; Krutvecho T; Tatsumi N
Asian Pac J Allergy Immunol; 2000 Jun; 18(2):105-8. PubMed ID: 10928623
[TBL] [Abstract][Full Text] [Related]
30. A novel mutation (g2172-->c) in the factor V gene in a Chinese family with hereditary activated protein C resistance.
Cai H; Hua B; Fan L; Wang Q; Wang S; Zhao Y
Thromb Res; 2010 Jun; 125(6):545-8. PubMed ID: 20304467
[TBL] [Abstract][Full Text] [Related]
31. The Leiden mutation of coagulation factor V in Hungarian SLE patients.
Regéczy N; Lakos G; Balogh I; Ajzner E; Kiss E; Szegedi G
Clin Appl Thromb Hemost; 2000 Jan; 6(1):41-5. PubMed ID: 10726048
[TBL] [Abstract][Full Text] [Related]
32. A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype.
Bernardi F; Faioni EM; Castoldi E; Lunghi B; Castaman G; Sacchi E; Mannucci PM
Blood; 1997 Aug; 90(4):1552-7. PubMed ID: 9269773
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneity of activated protein C resistance phenotype in subjects with compound heterozygosity for HR2 haplotype and FV Leiden mutation (R506Q) in factor V gene.
Castaman G; Ruggeri M; Tosetto A; Rodeghiero F
Thromb Haemost; 2000 Aug; 84(2):357-8. PubMed ID: 10959717
[No Abstract] [Full Text] [Related]
34. Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty.
Philipp CS; Dilley A; Saidi P; Evatt B; Austin H; Zawadsky J; Harwood D; Ellingsen D; Barnhart E; Phillips DJ; Hooper WC
Thromb Haemost; 1998 Dec; 80(6):869-73. PubMed ID: 9869151
[TBL] [Abstract][Full Text] [Related]
35. Activated protein C resistance and the FV:R506Q mutation in a random population sample--associations with cardiovascular risk factors and coagulation variables.
Lowe GD; Rumley A; Woodward M; Reid E; Rumley J
Thromb Haemost; 1999 Jun; 81(6):918-24. PubMed ID: 10404768
[TBL] [Abstract][Full Text] [Related]
36. Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism.
Bergrem A; Dahm AE; Jacobsen AF; Mowinckel MC; Sandvik L; Sandset PM
Br J Haematol; 2011 Jul; 154(2):241-7. PubMed ID: 21564075
[TBL] [Abstract][Full Text] [Related]
37. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L
Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913
[TBL] [Abstract][Full Text] [Related]
38. [Activated protein C resistance, Leiden mutation, anticoagulant proteins and fibrinogen levels in patients with deep venous thrombosis].
Jastrzebska M; Bałszan-Kowalska I; Ciechanowicz A; Bińczak-Kuleta A; Falkowski A; Chełstowski K
Pol Arch Med Wewn; 2003 Jun; 109(6):579-88. PubMed ID: 14567090
[TBL] [Abstract][Full Text] [Related]
39. Genetic polymorphisms on the factor V gene in women with recurrent miscarriage and acquired APCR.
Dawood F; Mountford R; Farquharson R; Quenby S
Hum Reprod; 2007 Sep; 22(9):2546-53. PubMed ID: 17640947
[TBL] [Abstract][Full Text] [Related]
40. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
Dahlbäck B
Semin Thromb Hemost; 1999; 25(3):273-89. PubMed ID: 10443959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]